VIB - Vlaams Instituut voor Biotechnologie

News

VIB Spin-off Oncurious announces Publication in Journal for Immunotherapy of Cancer

24/02/2021

ONCURIOUS NV, a Belgium-based biotech company focused on developing innovative oncology treatments designed to enhance T cell migration, infiltration and activity into resistant tumour sites, today reports the publication of a paper in the Journal for Immunotherapy of Cancer.

VIB welcomes new MSCA fellows

19/02/2021

Each year, the EU launches calls for postdoc research fellowships through the Marie Sklodowska-Curie Actions. The prestigious two-year funding of Marie Curie fellowships attracts an enormous number of applications, which makes these fellowships very competitive.

Qbic and Noshaq Seed finance new VUB spin-off Abscint

10/02/2021

A new VUB spin-off named ABSCINT NV was established. The spin-off is based on technology developed by the joint research efforts of the teams of Prof. Dr. Tony Lahoutte and Prof. Dr. Jo Van Ginderachter at VUB and VIB in Brussels.

VIB congratulates V-Bio Ventures on the launch of its second fund

04/02/2021

VIB is proud today to share V-Bio Ventures' announcement on the first close of their second fund at 78 million euro. V-Bio Fund 2 builds on the success of V-Bio's first fund, with 15 investments in outstanding companies that innovate in healthcare and agriculture.

no translation available Nieuwe veldproef met genetisch gewijzigde populier

27/01/2021

VIB heeft een aanvraag ingediend voor een nieuwe veldproef met genetisch gewijzigde populieren. De bomen hebben een gewijzigde houtsamenstelling waardoor het hout op een meer efficiënte en meer milieuvriendelijke manier kan worden omgezet naar suikers.

more news

Publications

TRP Channel Cooperation for Nociception: Therapeutic Opportunities.

Bamps D, Vriens J, De H, Voets T@

ANNU REV PHARMACOL TOXICOL

655-677

2021

DOI

10.1146/annurev-pharmtox-010919-023238

ß-Barrels covalently link peptidoglycan and the outer membrane in the a-proteobacterium Brucella abortus.

Godessart P, Lannoy A, Dieu M, Van der Verren S, Soumillion P, Collet J, Remaut H, Renard P, De B

10.1038/s41564-020-00799-3

Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.

Holvoet T*, Joossens M*, Vázquez Castellanos J, Christiaens E, Heyerick L, Boelens J, Verhasselt B, Van V, De V, Raes J°, DE L@

10.1053/j.gastro.2020.07.013

GoldenGateway: A DNA Assembly Method for Plant Biotechnology.

10.1016/j.tplants.2020.10.004

PED in 2021: a major update of the protein ensemble database for intrinsically disordered proteins.

VIB Facts Series

The VIB Facts series is a set of in-depth, science-based informational brochures on topics as diverse as animal testing, crop production, and genome engineering.
Every brochure has been curated by experts in the field to provide you with the most up-to-date information.

CHECK OUT THE ENTIRE SERIES

VIBTimes

VIB researchers are making new discoveries all the time. Find out what goes on behind the scenes. The quarterly VIBtimes newsletter gives you an inside look at the science conducted at VIB and introduces you to the people behind our successful breakthrough research.